Identity PoC

group of Merck & Co., Inc. (no name recorded)

group urn:matchory:group:01m772jzjzfz4rbgq75kyq0nb5 - status: current

Tab to a node, Enter opens it, e shows its neighbours.
linked needs review refused former (ended) named on the same website group entity site unit brand

Hover or focus a node for its relation and state.

Values

Show personal data (officers, owners and contact people who are natural persons; hidden by default)

No current values.

Offerings

39120000 Electrical equipment and components and supplies

OfferingKindRelationOwnerCommodityAspectsEvidence
WELIREG® product not stated Merck & Co., Inc. urn:matchory:entity:01m772jvs7erfr0e1r838h4117 (entity) 39121635 Voltage regulator (commodity)
  • products: WELIREG® https://www.merck.com/wp-content/uploads/sites/124/2026/11/Public-Pipeline-4Q2026-Merck.pdf
WELIREG™ product not stated Merck & Co., Inc. urn:matchory:entity:01m772jvs7erfr0e1r838h4117 (entity) 39121635 Voltage regulator (commodity)
  • products: WELIREG™ https://www.merck.com/research/product-pipeline/

51110000 Antineoplastic agents

OfferingKindRelationOwnerCommodityAspectsEvidence
KEYTRUDA QLEX™ product not stated Merck & Co., Inc. urn:matchory:entity:01m772jvs7erfr0e1r838h4117 (entity) 51111785 Pembrolizumab (commodity)
  • products: KEYTRUDA QLEX™ https://www.merck.com/research/product-pipeline/
  • extraction: KEYTRUDA QLEX™ https://www.merck.com/research/product-pipeline/
nemtabrutinib product not stated Merck & Co., Inc. urn:matchory:entity:01m772jvs7erfr0e1r838h4117 (entity) 51112022 Ibrutinib (commodity)
  • products: nemtabrutinib https://www.merck.com/research/product-pipeline/
TEMODAR® (temozolomide) Capsules and Injection product not stated Merck & Co., Inc. urn:matchory:entity:01m772jvs7erfr0e1r838h4117 (entity) 51112902 Temozolomide (commodity)
  • products: TEMODAR® (temozolomide) Capsules and Injection https://www.merck.com/products/

51120000 Antiarrythmics and antianginals and cardioplegics and drugs for heart failure

OfferingKindRelationOwnerCommodityAspectsEvidence
VERQUVO® (vericiguat) tablets, for oral use product not stated Merck & Co., Inc. urn:matchory:entity:01m772jvs7erfr0e1r838h4117 (entity) 51124500 Antiarrythmic sulfur compounds (class)
  • products: VERQUVO® (vericiguat) tablets, for oral use https://www.merck.com/products/

51160000 Drugs affecting the respiratory tract

OfferingKindRelationOwnerCommodityAspectsEvidence
OHTUVAYRE™(ensifentrine) inhalation suspension, for oral inhalation use product not stated Merck & Co., Inc. urn:matchory:entity:01m772jvs7erfr0e1r838h4117 (entity) 51161700 Drugs used for respiratory tract disorders (class)
  • products: OHTUVAYRE™(ensifentrine) inhalation suspension, for oral inhalation use https://www.merck.com/products/

51170000 Drugs affecting the gastrointestinal system

OfferingKindRelationOwnerCommodityAspectsEvidence
ANTIVENIN™ (LATRODECTUS MACTANS) product not stated Merck & Co., Inc. urn:matchory:entity:01m772jvs7erfr0e1r838h4117 (entity) 51172309 Antivenins (commodity)
  • products: ANTIVENIN™ (LATRODECTUS MACTANS) https://www.merck.com/products/
BRIDION® (sugammadex) Injection, for intravenous use product not stated Merck & Co., Inc. urn:matchory:entity:01m772jvs7erfr0e1r838h4117 (entity) 51172328 Sugammadex (commodity)
  • products: BRIDION® (sugammadex) Injection, for intravenous use https://www.merck.com/products/
EMEND® (aprepitant) capsules (aprepitant) for oral suspension product not stated Merck & Co., Inc. urn:matchory:entity:01m772jvs7erfr0e1r838h4117 (entity) 51171800 Antiemetics and antinauseants and antivertigo agents (class)
  • products: EMEND® (aprepitant) capsules (aprepitant) for oral suspension https://www.merck.com/products/
EMEND® (fosaprepitant) for injection, for intravenous use product not stated Merck & Co., Inc. urn:matchory:entity:01m772jvs7erfr0e1r838h4117 (entity) 51171838 Fosaprepitant or ivemend (commodity)
  • products: EMEND® (fosaprepitant) for injection, for intravenous use https://www.merck.com/products/

51180000 Hormones and hormone antagonists

OfferingKindRelationOwnerCommodityAspectsEvidence
efinopegdutide product not stated Merck & Co., Inc. urn:matchory:entity:01m772jvs7erfr0e1r838h4117 (entity) 51181500 Antidiabetic agents and hyperglycemic agents (class)
  • products: efinopegdutide https://www.merck.com/research/product-pipeline/
  • products: Merck Announces Positive Results from Phase 2b Trial of Efinopegdutide https://www.merck.com/investor-relations/
JANUMET® (sitagliptin and metformin hydrochloride) tablets, for oral use product not stated Merck & Co., Inc. urn:matchory:entity:01m772jvs7erfr0e1r838h4117 (entity) 51182709 Metformin/sitagliptin (commodity)
  • products: JANUMET® (sitagliptin and metformin hydrochloride) tablets, for oral use https://www.merck.com/products/
JANUMET® XR (sitagliptin and metformin hydrochloride extended-release) tablets, for oral use product not stated Merck & Co., Inc. urn:matchory:entity:01m772jvs7erfr0e1r838h4117 (entity) 51182709 Metformin/sitagliptin (commodity)
  • products: JANUMET® XR (sitagliptin and metformin hydrochloride extended-release) tablets, for oral use https://www.merck.com/products/
JANUVIA® (sitagliptin) tablets, for oral use product not stated Merck & Co., Inc. urn:matchory:entity:01m772jvs7erfr0e1r838h4117 (entity) 51183303 Sitagliptin (commodity)
  • products: JANUVIA® (sitagliptin) tablets, for oral use https://www.merck.com/products/
SEGLUROMET® (ertugliflozin and metformin) tablets, for oral use product not stated Merck & Co., Inc. urn:matchory:entity:01m772jvs7erfr0e1r838h4117 (entity) 51183505 Metformin (commodity)
  • products: SEGLUROMET® (ertugliflozin and metformin) tablets, for oral use https://www.merck.com/products/
STEGLUJAN® (ertugliflozin and sitagliptin) tablets, for oral use product not stated Merck & Co., Inc. urn:matchory:entity:01m772jvs7erfr0e1r838h4117 (entity) 51183300 Antidiabetic and hyperglycemic dipeptidyl peptidase-4 inhibitors (class)
  • products: STEGLUJAN® (ertugliflozin and sitagliptin) tablets, for oral use https://www.merck.com/products/

51200000 Immunomodulating drugs

OfferingKindRelationOwnerCommodityAspectsEvidence
adult vaccines product makes Merck & Co., Inc. urn:matchory:entity:01m772jvs7erfr0e1r838h4117 (entity) 51201600 Vaccines and antigens and toxoids (class)
  • products: Merck Patient Assistance Program provides certain Merck medicines and adult vaccines for free to qualified patients. https://www.merck.com/company-overview/culture-and-values/code-of-conduct/
BCG Vaccine (For Percutaneous Use) product not stated Merck & Co., Inc. urn:matchory:entity:01m772jvs7erfr0e1r838h4117 (entity) 51201647 Bacillus calmette–guerin or BCG vaccine (commodity)
  • products: BCG Vaccine (For Percutaneous Use) https://www.merck.com/products/
CAPVAXIVE™ (Pneumococcal 21 valent Conjugate Vaccine) product not stated Merck & Co., Inc. urn:matchory:entity:01m772jvs7erfr0e1r838h4117 (entity) 51201615 Pneumococcal vaccine (commodity)
  • products: CAPVAXIVE™ (Pneumococcal 21 valent Conjugate Vaccine) https://www.merck.com/products/
CAPVAXIVE™ (Pneumococcal 21-valent conjugate vaccine) product not stated Merck & Co., Inc. urn:matchory:entity:01m772jvs7erfr0e1r838h4117 (entity) 51201615 Pneumococcal vaccine (commodity)
  • products: CAPVAXIVE™ (Pneumococcal 21-valent conjugate vaccine) https://www.merck.com/media/media-library/
ERVEBO® (Ebola Zaire Vaccine, Live) Suspension for intramuscular injection product not stated Merck & Co., Inc. urn:matchory:entity:01m772jvs7erfr0e1r838h4117 (entity) 51201660 Ebola vaccine (commodity)
  • products: ERVEBO® (Ebola Zaire Vaccine, Live) Suspension for intramuscular injection https://www.merck.com/products/
GARDASIL® [Human Papillomavirus Quadrivalent (Types 6, 11, 16 and 18) Vaccine, Recombinant] product not stated Merck & Co., Inc. urn:matchory:entity:01m772jvs7erfr0e1r838h4117 (entity) 51201600 Vaccines and antigens and toxoids (class)
  • products: GARDASIL® [Human Papillomavirus Quadrivalent (Types 6, 11, 16 and 18) Vaccine, Recombinant] https://www.merck.com/products/
Liquid Pedvax HIB® [Haemophilus b Conjugate Vaccine (Meningococcal Protein Conjugate)] product not stated Merck & Co., Inc. urn:matchory:entity:01m772jvs7erfr0e1r838h4117 (entity) 51201627 Haemophilus B vaccine (commodity)
  • products: Liquid Pedvax HIB® [Haemophilus b Conjugate Vaccine (Meningococcal Protein Conjugate)] https://www.merck.com/products/
M-M-R® II [MEASLES, MUMPS, and RUBELLA VIRUS VACCINE LIVE] product not stated Merck & Co., Inc. urn:matchory:entity:01m772jvs7erfr0e1r838h4117 (entity) 51201628 Measles and mumps and rubella virus vaccine (commodity)
  • products: M-M-R® II [MEASLES, MUMPS, and RUBELLA VIRUS VACCINE LIVE] https://www.merck.com/products/
PNEUMOVAX® 23 [pneumococcal vaccine polyvalent] Sterile, Liquid Vaccine for Intramuscular or Subcutaneous Injection product not stated Merck & Co., Inc. urn:matchory:entity:01m772jvs7erfr0e1r838h4117 (entity) 51201615 Pneumococcal vaccine (commodity)
  • products: PNEUMOVAX® 23 [pneumococcal vaccine polyvalent] Sterile, Liquid Vaccine for Intramuscular or Subcutaneous Injection https://www.merck.com/products/
ProQuad® [Measles, Mumps, Rubella and Varicella Virus Vaccine Live] Lyophilized preparation for subcutaneous injection product not stated Merck & Co., Inc. urn:matchory:entity:01m772jvs7erfr0e1r838h4117 (entity) 51201648 Rubella and mumps virus vaccine (commodity)
  • products: ProQuad® [Measles, Mumps, Rubella and Varicella Virus Vaccine Live] Lyophilized preparation for subcutaneous injection https://www.merck.com/products/
RECOMBIVAX HB® [HEPATITIS B VACCINE (RECOMBINANT)] product not stated Merck & Co., Inc. urn:matchory:entity:01m772jvs7erfr0e1r838h4117 (entity) 51201607 Hepatitis B virus vaccine (commodity)
  • products: RECOMBIVAX HB® [HEPATITIS B VACCINE (RECOMBINANT)] https://www.merck.com/products/
RotaTeq® [Rotavirus Vaccine, Live, Oral, Pentavalent] Oral Solution product not stated Merck & Co., Inc. urn:matchory:entity:01m772jvs7erfr0e1r838h4117 (entity) 51201618 Rota virus vaccine (commodity)
  • products: RotaTeq® [Rotavirus Vaccine, Live, Oral, Pentavalent] Oral Solution https://www.merck.com/products/
TICE® BCG BCG LIVE (FOR INTRAVESICAL USE) product not stated Merck & Co., Inc. urn:matchory:entity:01m772jvs7erfr0e1r838h4117 (entity) 51201647 Bacillus calmette–guerin or BCG vaccine (commodity)
  • products: TICE® BCG BCG LIVE (FOR INTRAVESICAL USE) https://www.merck.com/products/
VAQTA® [Hepatitis A Vaccine, Inactivated] product not stated Merck & Co., Inc. urn:matchory:entity:01m772jvs7erfr0e1r838h4117 (entity) 51201626 Hepatitis A virus vaccine (commodity)
  • products: VAQTA® [Hepatitis A Vaccine, Inactivated] https://www.merck.com/products/
VARIVAX® [Varicella Virus Vaccine Live] product not stated Merck & Co., Inc. urn:matchory:entity:01m772jvs7erfr0e1r838h4117 (entity) 51201624 Varicella virus vaccine (commodity)
  • products: VARIVAX® [Varicella Virus Vaccine Live] https://www.merck.com/products/
VAXELIS® (Diphtheria and Tetanus Toxoids and Acellular Pertussis, Inactivated Poliovirus, Haemophilus b Conjugate and Hepatitis B Vaccine) product not stated Merck & Co., Inc. urn:matchory:entity:01m772jvs7erfr0e1r838h4117 (entity) 51201621 Tetanus vaccine (commodity)
  • products: VAXELIS® (Diphtheria and Tetanus Toxoids and Acellular Pertussis, Inactivated Poliovirus, Haemophilus b Conjugate and Hepatitis B Vaccine) https://www.merck.com/products/
VAXNEUVANCE® (Pneumococcal 15 valent Conjugate Vaccine) Suspension for Intramuscular Injection product not stated Merck & Co., Inc. urn:matchory:entity:01m772jvs7erfr0e1r838h4117 (entity) 51201615 Pneumococcal vaccine (commodity)
  • products: VAXNEUVANCE® (Pneumococcal 15 valent Conjugate Vaccine) Suspension for Intramuscular Injection https://www.merck.com/products/

51280000 Antibacterials

OfferingKindRelationOwnerCommodityAspectsEvidence
CANCIDAS® (caspofungin acetate) for Injection, for intravenous use product not stated Merck & Co., Inc. urn:matchory:entity:01m772jvs7erfr0e1r838h4117 (entity) 51283107 Caspofungin acetate (commodity)
  • products: CANCIDAS® (caspofungin acetate) for Injection, for intravenous use https://www.merck.com/products/
INVANZ® (ertapenem for injection) for intravenous (IV) or intramuscular (IM) use product not stated Merck & Co., Inc. urn:matchory:entity:01m772jvs7erfr0e1r838h4117 (entity) 51284603 Ertapenem (commodity)
  • products: INVANZ® (ertapenem for injection) for intravenous (IV) or intramuscular (IM) use https://www.merck.com/products/
LIPFENDRA® product not stated Merck & Co., Inc. urn:matchory:entity:01m772jvs7erfr0e1r838h4117 (entity) 51283101 Anidulafungin (commodity)
  • products: LIPFENDRA® https://www.merck.com/research/product-pipeline/
PRIMAXIN® I.V. (imipenem and cilastatin) for Injection, for intravenous use product not stated Merck & Co., Inc. urn:matchory:entity:01m772jvs7erfr0e1r838h4117 (entity) 51284903 Cilastatin/imipenem (commodity)
  • products: PRIMAXIN® I.V. (imipenem and cilastatin) for Injection, for intravenous use https://www.merck.com/products/
RECARBRIO® (imipenem, cilastatin, and relebactam) for injection, for intravenous use product not stated Merck & Co., Inc. urn:matchory:entity:01m772jvs7erfr0e1r838h4117 (entity) 51284903 Cilastatin/imipenem (commodity)
  • products: RECARBRIO® (imipenem, cilastatin, and relebactam) for injection, for intravenous use https://www.merck.com/products/
SIVEXTRO® (tedizolid phosphate) for injection, for intravenous use product not stated Merck & Co., Inc. urn:matchory:entity:01m772jvs7erfr0e1r838h4117 (entity) 51283300 Oxazolidinones (class)
  • products: SIVEXTRO® (tedizolid phosphate) for injection, for intravenous use https://www.merck.com/products/
SIVEXTRO® (tedizolid phosphate) tablet, for oral use product not stated Merck & Co., Inc. urn:matchory:entity:01m772jvs7erfr0e1r838h4117 (entity) 51283300 Oxazolidinones (class)
  • products: SIVEXTRO® (tedizolid phosphate) tablet, for oral use https://www.merck.com/products/
ZERBAXA® (ceftolozane and tazobactam) for injection, for intravenous use product not stated Merck & Co., Inc. urn:matchory:entity:01m772jvs7erfr0e1r838h4117 (entity) 51285004 Ceftolozane/Tazobactam (commodity)
  • products: ZERBAXA® (ceftolozane and tazobactam) for injection, for intravenous use https://www.merck.com/products/

51300000 Antifungal drugs

OfferingKindRelationOwnerCommodityAspectsEvidence
NOXAFIL® (posaconazole) injection, for intravenous use, delayed-release tablets, for oral use, and oral suspension product not stated Merck & Co., Inc. urn:matchory:entity:01m772jvs7erfr0e1r838h4117 (entity) 51303400 Antifungal triazoles (class)
  • products: NOXAFIL® (posaconazole) injection, for intravenous use, delayed-release tablets, for oral use, and oral suspension https://www.merck.com/products/

51320000 Antihyperlipidemic and hypocholesterolemic agents

OfferingKindRelationOwnerCommodityAspectsEvidence
LIPFENDRA® (enlicitide) tablets product not stated Merck & Co., Inc. urn:matchory:entity:01m772jvs7erfr0e1r838h4117 (entity) 51321800 Antihyperlipidemic and hypocholesterolemic fibric acids (class) tablets 20 mg mg (LIPFENDRA® (enlicitide) tablets 20 mg)
  • products: LIPFENDRA® (enlicitide) tablets 20 mg https://www.merck.com/media/media-library/
LIPFENDRA® (enlicitide) tablets, for oral use product not stated Merck & Co., Inc. urn:matchory:entity:01m772jvs7erfr0e1r838h4117 (entity) 51321800 Antihyperlipidemic and hypocholesterolemic fibric acids (class)
  • products: LIPFENDRA® (enlicitide) tablets, for oral use https://www.merck.com/products/

51340000 Antiviral drugs

OfferingKindRelationOwnerCommodityAspectsEvidence
alimatravir product makes Merck & Co., Inc. urn:matchory:entity:01m772jvs7erfr0e1r838h4117 (entity) 51342500 Antiviral nucleosides (class)
  • products: alimatravir https://www.merck.com/research/product-pipeline/
DELSTRIGO® (doravirine, lamivudine, and tenofovir disoproxil fumarate) tablets, for oral use product not stated Merck & Co., Inc. urn:matchory:entity:01m772jvs7erfr0e1r838h4117 (entity) 51343816 Lamivudine/tenofovir DF (commodity)
  • products: DELSTRIGO® (doravirine, lamivudine, and tenofovir disoproxil fumarate) tablets, for oral use https://www.merck.com/products/
efitazanamivir alfa product not stated Merck & Co., Inc. urn:matchory:entity:01m772jvs7erfr0e1r838h4117 (entity) 51341901 Zanamivir (commodity)
  • products: efitazanamivir alfa https://www.merck.com/research/product-pipeline/
IDVYNSO™ (doravirine and islatravir) tablets, for oral use product not stated Merck & Co., Inc. urn:matchory:entity:01m772jvs7erfr0e1r838h4117 (entity) 51343800 Combination antivirals (class)
  • products: IDVYNSO™ (doravirine and islatravir) tablets, for oral use https://www.merck.com/products/
ISENTRESS® HD (raltegravir) film-coated tablets, for oral use product not stated Merck & Co., Inc. urn:matchory:entity:01m772jvs7erfr0e1r838h4117 (entity) 51343201 Raltegravir (commodity)
  • products: ISENTRESS® HD (raltegravir) film-coated tablets, for oral use https://www.merck.com/products/
ISENTRESS® (raltegravir) chewable tablets, for oral use product not stated Merck & Co., Inc. urn:matchory:entity:01m772jvs7erfr0e1r838h4117 (entity) 51343201 Raltegravir (commodity)
  • products: ISENTRESS® (raltegravir) chewable tablets, for oral use https://www.merck.com/products/
ISENTRESS® (raltegravir) film-coated tablets, for oral use product not stated Merck & Co., Inc. urn:matchory:entity:01m772jvs7erfr0e1r838h4117 (entity) 51343201 Raltegravir (commodity)
  • products: ISENTRESS® (raltegravir) film-coated tablets, for oral use https://www.merck.com/products/
ISENTRESS® (raltegravir) for oral suspension product not stated Merck & Co., Inc. urn:matchory:entity:01m772jvs7erfr0e1r838h4117 (entity) 51343201 Raltegravir (commodity)
  • products: ISENTRESS® (raltegravir) for oral suspension https://www.merck.com/products/
islatravir + lenacapavir product not stated Merck & Co., Inc. urn:matchory:entity:01m772jvs7erfr0e1r838h4117 (entity) 51343800 Combination antivirals (class)
  • products: islatravir + lenacapavir https://www.merck.com/research/product-pipeline/
islatravir + ulonivirine product not stated Merck & Co., Inc. urn:matchory:entity:01m772jvs7erfr0e1r838h4117 (entity) 51343800 Combination antivirals (class)
  • products: islatravir + ulonivirine https://www.merck.com/research/product-pipeline/
  • extraction: islatravir + ulonivirine https://www.merck.com/research/product-pipeline/
LAGEVRIO® product not stated Merck & Co., Inc. urn:matchory:entity:01m772jvs7erfr0e1r838h4117 (entity) 51343812 Glecaprevir/Pibrentasvir (commodity)
  • products: LAGEVRIO® https://www.merck.com/wp-content/uploads/sites/124/2026/11/Public-Pipeline-4Q2026-Merck.pdf
LAGEVRIO™ product not stated Merck & Co., Inc. urn:matchory:entity:01m772jvs7erfr0e1r838h4117 (entity) 51343809 Dolutegravir/Abacavir/Lamivudine (commodity)
  • products: LAGEVRIO™ https://www.merck.com/research/product-pipeline/
PIFELTRO® (doravirine) tablets, for oral use product not stated Merck & Co., Inc. urn:matchory:entity:01m772jvs7erfr0e1r838h4117 (entity) 51343000 Antiviral pyridines (class)
  • products: PIFELTRO® (doravirine) tablets, for oral use https://www.merck.com/products/
PREVYMIS® (letermovir) injection, for intravenous use product not stated Merck & Co., Inc. urn:matchory:entity:01m772jvs7erfr0e1r838h4117 (entity) 51343100 Antiviral pyrimidines (class)
  • products: PREVYMIS® (letermovir) injection, for intravenous use https://www.merck.com/products/
PREVYMIS® (letermovir) oral pellets product not stated Merck & Co., Inc. urn:matchory:entity:01m772jvs7erfr0e1r838h4117 (entity) 51343000 Antiviral pyridines (class)
  • products: PREVYMIS® (letermovir) oral pellets https://www.merck.com/products/
PREVYMIS® (letermovir) tablets, for oral use product not stated Merck & Co., Inc. urn:matchory:entity:01m772jvs7erfr0e1r838h4117 (entity) 51343000 Antiviral pyridines (class)
  • products: PREVYMIS® (letermovir) tablets, for oral use https://www.merck.com/products/
ZEPATIER® (elbasvir and grazoprevir) tablets, for oral use product not stated Merck & Co., Inc. urn:matchory:entity:01m772jvs7erfr0e1r838h4117 (entity) 51343800 Combination antivirals (class)
  • products: ZEPATIER® (elbasvir and grazoprevir) tablets, for oral use https://www.merck.com/products/

51450000 Anthelmintics

OfferingKindRelationOwnerCommodityAspectsEvidence
Mectizan® product not stated Merck & Co., Inc. urn:matchory:entity:01m772jvs7erfr0e1r838h4117 (entity) 51452801 Ivermectin (commodity)
  • products: Mectizan® https://www.merck.com/media/
STROMECTOL® (IVERMECTIN) TABLETS product not stated Merck & Co., Inc. urn:matchory:entity:01m772jvs7erfr0e1r838h4117 (entity) 51452801 Ivermectin (commodity)
  • products: STROMECTOL® (IVERMECTIN) TABLETS https://www.merck.com/products/

83120000 Information services

OfferingKindRelationOwnerCommodityAspectsEvidence
Merck Manuals service not stated Merck & Co., Inc. urn:matchory:entity:01m772jvs7erfr0e1r838h4117 (entity) 83121600 Information centers (class)
  • products: [Merck Manuals](https://www.merckmanuals.com/) Medical information source covering thousands of topics in all fields of medicine. https://www.merck.com/company-overview/culture-and-values/code-of-conduct/

No UNSPSC commodity

OfferingKindRelationOwnerCommodityAspectsEvidence
animal health products product makes Merck & Co., Inc. urn:matchory:entity:01m772jvs7erfr0e1r838h4117 (entity) none confirmed
  • products: Merck is a global health care company that delivers innovative health solutions through its prescription medicines, vaccines, preventive options, biologic therapies and animal health products. https://www.merck.com/media/media-library/
BELSOMRA® (suvorexant) tablets, for oral use, C-IV product not stated Merck & Co., Inc. urn:matchory:entity:01m772jvs7erfr0e1r838h4117 (entity) none confirmed
  • products: BELSOMRA® (suvorexant) tablets, for oral use, C-IV https://www.merck.com/products/
biologic therapies product makes Merck & Co., Inc. urn:matchory:entity:01m772jvs7erfr0e1r838h4117 (entity) none confirmed
  • products: Merck is a global health care company that delivers innovative health solutions through its prescription medicines, vaccines, preventive options, biologic therapies and animal health products. https://www.merck.com/media/media-library/
bomedemstat product not stated Merck & Co., Inc. urn:matchory:entity:01m772jvs7erfr0e1r838h4117 (entity) none confirmed
  • products: bomedemstat https://www.merck.com/research/product-pipeline/
calderasib product not stated Merck & Co., Inc. urn:matchory:entity:01m772jvs7erfr0e1r838h4117 (entity) none confirmed
  • products: calderasib https://www.merck.com/research/product-pipeline/
CAPVAXIVE product not stated Merck & Co., Inc. urn:matchory:entity:01m772jvs7erfr0e1r838h4117 (entity) none confirmed
  • products: CAPVAXIVE https://www.merck.com/wp-content/uploads/sites/124/2026/11/Public-Pipeline-4Q2026-Merck.pdf
DIFICID® (fidaxomicin) for Oral Suspension product not stated Merck & Co., Inc. urn:matchory:entity:01m772jvs7erfr0e1r838h4117 (entity) none confirmed
  • products: DIFICID® (fidaxomicin) for Oral Suspension https://www.merck.com/products/
DIFICID® (fidaxomicin) tablets, for oral use product not stated Merck & Co., Inc. urn:matchory:entity:01m772jvs7erfr0e1r838h4117 (entity) none confirmed
  • products: DIFICID® (fidaxomicin) tablets, for oral use https://www.merck.com/products/
ENFLONSIA product makes Merck & Co., Inc. urn:matchory:entity:01m772jvs7erfr0e1r838h4117 (entity) none confirmed
  • products: ENFLONSIA https://www.merck.com/wp-content/uploads/sites/124/2026/11/Public-Pipeline-4Q2026-Merck.pdf
ENFLONSIA™ product not stated Merck & Co., Inc. urn:matchory:entity:01m772jvs7erfr0e1r838h4117 (entity) none confirmed
  • products: ENFLONSIA™ https://www.merck.com/research/product-pipeline/
ENFLONSIA™ (clesrovimab-cfor) for Injection product not stated Merck & Co., Inc. urn:matchory:entity:01m772jvs7erfr0e1r838h4117 (entity) none confirmed
  • products: ENFLONSIA™ (clesrovimab-cfor) for Injection https://www.merck.com/media/media-library/
ENFLONSIA™ (clesrovimab-cfor) injection, for intramuscular use product not stated Merck & Co., Inc. urn:matchory:entity:01m772jvs7erfr0e1r838h4117 (entity) none confirmed
  • products: ENFLONSIA™ (clesrovimab-cfor) injection, for intramuscular use https://www.merck.com/products/
ensifentrine (+) glycopyrrolate product not stated Merck & Co., Inc. urn:matchory:entity:01m772jvs7erfr0e1r838h4117 (entity) none confirmed
  • products: ensifentrine (+) glycopyrrolate https://www.merck.com/research/product-pipeline/
GARDASIL®9 (Human Papillomavirus 9-valent Vaccine, Recombinant) Suspension for intramuscular injection product not stated Merck & Co., Inc. urn:matchory:entity:01m772jvs7erfr0e1r838h4117 (entity) none confirmed
  • products: GARDASIL®9 (Human Papillomavirus 9-valent Vaccine, Recombinant) Suspension for intramuscular injection https://www.merck.com/products/
gocatamig product not stated Merck & Co., Inc. urn:matchory:entity:01m772jvs7erfr0e1r838h4117 (entity) none confirmed
  • products: gocatamig https://www.merck.com/research/product-pipeline/
IDVYNSO product not stated Merck & Co., Inc. urn:matchory:entity:01m772jvs7erfr0e1r838h4117 (entity) none confirmed
  • products: IDVYNSO https://www.merck.com/wp-content/uploads/sites/124/2026/11/Public-Pipeline-4Q2026-Merck.pdf
IDVYNSO™ product not stated Merck & Co., Inc. urn:matchory:entity:01m772jvs7erfr0e1r838h4117 (entity) none confirmed
  • products: IDVYNSO™ https://www.merck.com/research/product-pipeline/
ifinatamab deruxtecan product not stated Merck & Co., Inc. urn:matchory:entity:01m772jvs7erfr0e1r838h4117 (entity) none confirmed
  • products: ifinatamab deruxtecan https://www.merck.com/research/product-pipeline/
intismeran autogene product not stated Merck & Co., Inc. urn:matchory:entity:01m772jvs7erfr0e1r838h4117 (entity) none confirmed
  • products: intismeran autogene https://www.merck.com/research/product-pipeline/
KEYTRUDA® product not stated Merck & Co., Inc. urn:matchory:entity:01m772jvs7erfr0e1r838h4117 (entity) none confirmed
  • products: KEYTRUDA® https://www.merck.com/research/product-pipeline/
KEYTRUDA® (pembrolizumab) product not stated Merck & Co., Inc. urn:matchory:entity:01m772jvs7erfr0e1r838h4117 (entity) none confirmed
  • products: KEYTRUDA® (pembrolizumab) https://www.merck.com/media/
KEYTRUDA® (pembrolizumab) Injection product not stated Merck & Co., Inc. urn:matchory:entity:01m772jvs7erfr0e1r838h4117 (entity) none confirmed
  • products: KEYTRUDA® (pembrolizumab) Injection https://www.merck.com/media/media-library/
KEYTRUDA® (pembrolizumab) injection, for intravenous use product not stated Merck & Co., Inc. urn:matchory:entity:01m772jvs7erfr0e1r838h4117 (entity) none confirmed
  • products: KEYTRUDA® (pembrolizumab) injection, for intravenous use https://www.merck.com/products/
KEYTRUDA QLEX product makes Merck & Co., Inc. urn:matchory:entity:01m772jvs7erfr0e1r838h4117 (entity) none confirmed
  • products: KEYTRUDA QLEX https://www.merck.com/wp-content/uploads/sites/124/2026/11/Public-Pipeline-4Q2026-Merck.pdf
KEYTRUDA QLEX TM (pembrolizumab and berahyaluronidase alfa-pmph) for Injection product not stated Merck & Co., Inc. urn:matchory:entity:01m772jvs7erfr0e1r838h4117 (entity) none confirmed
  • products: KEYTRUDA QLEX TM (pembrolizumab and berahyaluronidase alfa-pmph) for Injection https://www.merck.com/media/media-library/
  • extraction: KEYTRUDA QLEX TM (pembrolizumab and berahyaluronidase alfa-pmph) for Injection https://www.merck.com/media/media-library/
KEYTRUDA QLEX™ (pembrolizumab and berahyaluronidase alfa-pmph) injection, for subcutaneous use product not stated Merck & Co., Inc. urn:matchory:entity:01m772jvs7erfr0e1r838h4117 (entity) none confirmed
  • products: KEYTRUDA QLEX™ (pembrolizumab and berahyaluronidase alfa-pmph) injection, for subcutaneous use https://www.merck.com/products/
LYNPARZA® product not stated Merck & Co., Inc. urn:matchory:entity:01m772jvs7erfr0e1r838h4117 (entity) none confirmed
  • products: LYNPARZA® https://www.merck.com/research/product-pipeline/
medicines product makes Merck & Co., Inc. urn:matchory:entity:01m772jvs7erfr0e1r838h4117 (entity) none confirmed
  • products: research, develop, communicate and sell our medicines, vaccines, and other products https://www.merck.com/company-overview/culture-and-values/code-of-conduct/
Merck Access Program service not stated Merck & Co., Inc. urn:matchory:entity:01m772jvs7erfr0e1r838h4117 (entity) none confirmed
  • products: [Merck Access Program](https://www.merckaccessprogram.com/) Information about insurance coverage and financial assistance options for eligible patients. https://www.merck.com/products/
Merck medicines product not stated Merck & Co., Inc. urn:matchory:entity:01m772jvs7erfr0e1r838h4117 (entity) none confirmed
  • products: Merck Patient Assistance Program provides certain Merck medicines and adult vaccines for free to qualified patients. https://www.merck.com/investor-relations/
Merck Patient Assistance Program service not stated Merck & Co., Inc. urn:matchory:entity:01m772jvs7erfr0e1r838h4117 (entity) none confirmed
  • products: Merck Patient Assistance Program provides certain Merck medicines and adult vaccines for free to qualified patients. https://www.merck.com/products/
MK-1045 product not stated Merck & Co., Inc. urn:matchory:entity:01m772jvs7erfr0e1r838h4117 (entity) none confirmed
  • products: MK-1045 https://www.merck.com/research/product-pipeline/
MK-2010 product not stated Merck & Co., Inc. urn:matchory:entity:01m772jvs7erfr0e1r838h4117 (entity) none confirmed
  • products: MK-2010 https://www.merck.com/research/product-pipeline/
MK-2214 product not stated Merck & Co., Inc. urn:matchory:entity:01m772jvs7erfr0e1r838h4117 (entity) none confirmed
  • products: MK-2214 https://www.merck.com/research/product-pipeline/
MK-7262 product not stated Merck & Co., Inc. urn:matchory:entity:01m772jvs7erfr0e1r838h4117 (entity) none confirmed
  • products: MK-7262 https://www.merck.com/research/product-pipeline/
MK-8690 product not stated Merck & Co., Inc. urn:matchory:entity:01m772jvs7erfr0e1r838h4117 (entity) none confirmed
  • products: MK-8690 https://www.merck.com/research/product-pipeline/
MK-8748 product not stated Merck & Co., Inc. urn:matchory:entity:01m772jvs7erfr0e1r838h4117 (entity) none confirmed
  • products: MK-8748 https://www.merck.com/research/product-pipeline/
OHTUVAYRE® product not stated Merck & Co., Inc. urn:matchory:entity:01m772jvs7erfr0e1r838h4117 (entity) none confirmed
  • products: OHTUVAYRE® https://www.merck.com/research/product-pipeline/
OHTUVAYRE® (ensifentrine) product not stated Merck & Co., Inc. urn:matchory:entity:01m772jvs7erfr0e1r838h4117 (entity) none confirmed
  • products: Merck Initiates Phase 3 Study Evaluating OHTUVAYRE® (ensifentrine) https://www.merck.com/investor-relations/
opevesostat product not stated Merck & Co., Inc. urn:matchory:entity:01m772jvs7erfr0e1r838h4117 (entity) none confirmed
  • products: opevesostat https://www.merck.com/research/product-pipeline/
patritumab deruxtecan product not stated Merck & Co., Inc. urn:matchory:entity:01m772jvs7erfr0e1r838h4117 (entity) none confirmed
  • products: patritumab deruxtecan https://www.merck.com/research/product-pipeline/
pharmaceutical products product not stated Merck & Co., Inc. urn:matchory:entity:01m772jvs7erfr0e1r838h4117 (entity) none confirmed
  • products: pharmaceutical products https://www.merck.com/wp-content/uploads/sites/124/2025/03/EOS-Handbook-_March-2025.pdf
pharmaceuticals product makes Merck & Co., Inc. urn:matchory:entity:01m772jvs7erfr0e1r838h4117 (entity) none confirmed
  • products: Merck pharmaceuticals and vaccines https://www.merck.com/wp-content/uploads/sites/124/2025/03/EOS-Handbook-_March-2025.pdf
prescription medicines product makes Merck & Co., Inc. urn:matchory:entity:01m772jvs7erfr0e1r838h4117 (entity) none confirmed
  • products: Merck is a global health care company that delivers innovative health solutions through its prescription medicines, vaccines, preventive options, biologic therapies and animal health products. https://www.merck.com/media/media-library/
raludotatug deruxtecan product not stated Merck & Co., Inc. urn:matchory:entity:01m772jvs7erfr0e1r838h4117 (entity) none confirmed
  • products: raludotatug deruxtecan https://www.merck.com/research/product-pipeline/
remigromig product not stated Merck & Co., Inc. urn:matchory:entity:01m772jvs7erfr0e1r838h4117 (entity) none confirmed
  • products: remigromig https://www.merck.com/research/product-pipeline/
sacituzumab tirumotecan product not stated Merck & Co., Inc. urn:matchory:entity:01m772jvs7erfr0e1r838h4117 (entity) none confirmed
  • products: sacituzumab tirumotecan https://www.merck.com/research/product-pipeline/
STEGLATRO® (ertugliflozin) tablets, for oral use product not stated Merck & Co., Inc. urn:matchory:entity:01m772jvs7erfr0e1r838h4117 (entity) none confirmed
  • products: STEGLATRO® (ertugliflozin) tablets, for oral use https://www.merck.com/products/
tulisokibart product not stated Merck & Co., Inc. urn:matchory:entity:01m772jvs7erfr0e1r838h4117 (entity) none confirmed
  • products: tulisokibart https://www.merck.com/research/product-pipeline/
V181 product not stated Merck & Co., Inc. urn:matchory:entity:01m772jvs7erfr0e1r838h4117 (entity) none confirmed
  • products: V181 https://www.merck.com/research/product-pipeline/
vaccines product makes Merck & Co., Inc. urn:matchory:entity:01m772jvs7erfr0e1r838h4117 (entity) none confirmed
  • products: Merck is a global health care company that delivers innovative health solutions through its prescription medicines, vaccines, preventive options, biologic therapies and animal health products. https://www.merck.com/media/media-library/
WELIREG® (belzutifan) tablets, for oral use product not stated Merck & Co., Inc. urn:matchory:entity:01m772jvs7erfr0e1r838h4117 (entity) none confirmed
  • products: WELIREG® (belzutifan) tablets, for oral use https://www.merck.com/products/
WINREVAIR product not stated Merck & Co., Inc. urn:matchory:entity:01m772jvs7erfr0e1r838h4117 (entity) none confirmed
  • products: WINREVAIR https://www.merck.com/wp-content/uploads/sites/124/2026/11/Public-Pipeline-4Q2026-Merck.pdf
WINREVAIR™ product not stated Merck & Co., Inc. urn:matchory:entity:01m772jvs7erfr0e1r838h4117 (entity) none confirmed
  • products: WINREVAIR™ https://www.merck.com/research/product-pipeline/
WINREVAIR™ (sotatercept-csrk) for Injection product not stated Merck & Co., Inc. urn:matchory:entity:01m772jvs7erfr0e1r838h4117 (entity) none confirmed
  • products: WINREVAIR™ (sotatercept-csrk) for Injection https://www.merck.com/media/media-library/
WINREVAIR™ (sotatercept-csrk) for injection, for subcutaneous use product not stated Merck & Co., Inc. urn:matchory:entity:01m772jvs7erfr0e1r838h4117 (entity) none confirmed
  • products: WINREVAIR™ (sotatercept-csrk) for injection, for subcutaneous use https://www.merck.com/products/
zilovertamab vedotin product not stated Merck & Co., Inc. urn:matchory:entity:01m772jvs7erfr0e1r838h4117 (entity) none confirmed
  • products: zilovertamab vedotin https://www.merck.com/research/product-pipeline/
ZINPLAVA™ (bezlotoxumab) injection, for intravenous use product not stated Merck & Co., Inc. urn:matchory:entity:01m772jvs7erfr0e1r838h4117 (entity) none confirmed
  • products: ZINPLAVA™ (bezlotoxumab) injection, for intravenous use https://www.merck.com/products/
ZOLINZA® (vorinostat capsules, for oral use) product not stated Merck & Co., Inc. urn:matchory:entity:01m772jvs7erfr0e1r838h4117 (entity) none confirmed
  • products: ZOLINZA® (vorinostat capsules, for oral use) https://www.merck.com/products/

Identifiers

No identifiers.

Relations

No relations.

Groups

Not in a group.

Merged into this subject

No other URN was merged into this one.

Actions

an agent checks the company's website and other sources and adds claims with quotes